$STIM News

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Neuronetics Appoints Nir Naor CFO, Effective July 23,

BTIG Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5

Neuronetics: Top Line Growth, Low Valuation, But Gross Margin Struggles

Neuronetics Could Double, But The Balance Sheet May Crack First

Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit

Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026

Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer

Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

Neuronetics Collaborates With ANT Neuro To Expand NeuroStar Advanced Therapy System

Neuronetics, Inc. Q1 2026 Earnings Call Summary

Neuronetics (STIM) Q1 2026 Earnings Transcript

Neuronetics, Inc. (STIM) Q1 2026 Earnings Call Transcript

Neuronetics Inc (NASDAQ:STIM) Posts Narrower Loss in Q1 2026, Pre-Market Rises Despite Revenue Miss

Neuronetics Reports First Quarter 2026 Financial and Operating Results

Full Transcript: Neuronetics Q1 2026 Earnings Call